The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
Open accessAbstract
To elucidate the cellular mechanism by which angiotensin II (ANG II) induces cardiac hypertrophy, we investigated the possible autocrine/paracrine role of endogenous endothelin-1 (ET-1) in ANG II-induced hypertrophy of neonatal rat cardiomyocytes by use of synthetic ET-1 receptor antagonist and antisense oligonucleotides to preproET-1 (ppET-1) mRNA. Northern blot analysis and in situ hybridization revealed that ppET-1 mRNA was expressed in cardiomyocytes, but, to a lesser extent, in nonmyocytes as well. ANG II upregulated ppET-1 mRNA level by threefold over control level as early as 30 min, and it stimulated release of immunoreactive ET-1 from cardiomyocytes in a dose- and time-dependent manner. ET-1 stimulated ppET-1 mRNA levels after 30 min in a similar fashion as ANG II. Tetradecanoylphorbol-acetate (10(-7) M) mimicked the effects of ANG II and ET-1 on induction of ppET-1 mRNA. ANG II-induced ppET-1 gene expression was completely blocked by protein kinase C inhibitor H-7 or by down-regulation of endogenous protein kinase C by pretreatment with phorbol ester. ET-1 and ANG II stimulated twofold increase [3H]leucine incorporation into cardiomyocytes, whose effects were similarly and dose dependently inhibited by endothelin A receptor antagonist (BQ123). Introduction of antisense sequence against coding region of ppET-1 mRNA into cardiomyocytes resulted in complete blockade with ppET-1 mRNA levels and [3H]leucine incorporation stimulated by ANG II. These results suggest that endogenous ET-1 locally generated and secreted by cardiomyocytes may contribute to ANG II-induced cardiac hypertrophy via an autocrine/paracrine fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,915
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
Lee, W., Mitchell, P., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90612-x · Cited by 1,983
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor
Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., & Yano, M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90331-i · Cited by 869
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
Hélène, C., & Toulmé, J.-J. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90031-v · Cited by 768
Shubeita, H. E., McDonough, P. M., Harris, A. N., Knowlton, K. U., Glembotski, C. C., Brown, J. H., & Chien, K. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30538-0 · Cited by 645
Fos-Associated Protein p39 Is the Product of the jun Proto-Oncogene
Rauscher, F. J., Cohen, D. R., Curran, T., Bos, T. J., Vogt, P. K., Bohmann, D., Tjian, R., & Franza, B. R. (1988) · Science · doi:10.1126/science.3130660 · Cited by 629
Nonpeptide angiotensin II receptor antagonists
Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., & Herblin, W. F. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90498-h · Cited by 549
Ito, H., Hirata, Y., Hiroe, M., Tsujino, M., Adachi, S., Takamoto, T., Nitta, M., Taniguchi, K., & Marumo, F. (1991) · Circulation Research · doi:10.1161/01.res.69.1.209 · Cited by 503
Self-citationEndothelin is a potent mitogen for rat vascular smooth muscle cells
Hirata, Y., Takagi, Y., Fukuda, Y., & Maruno, F. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90227-x · Cited by 501
Self-citationTakuwa, N., Takuwa, Y., Yanagisawa, M., Yamashita, K., & Masaki, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83121-0 · Cited by 477
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
The Human Preproendothelin-1 Gene
Inoue, A., Yanagisawa, M., Takuwa, Y., Mitsui, Y., Kobayashi, M., & Masaki, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63795-0 · Cited by 436
Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
Imai, T., Hirata, Y., Emori, T., Yanagisawa, M., Masaki, T., & Marumo, F. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.753 · Cited by 359
Self-citationAngiotensin II stimulation of protein synthesis and cell growth in chick heart cells
Baker, K. M., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h610 · Cited by 353
Ito, H., Miller, S. C., Billingham, M. E., Akimoto, H., Torti, S. V., Wade, R., Gahlmann, R., Lyons, G., Kedes, L., & Torti, F. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4275 · Cited by 255
Self-citationcDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA
Sakurai, T., Yanagisawa, M., Inoue, A., Ryan, U. S., Kimura, S., Mitsui, Y., Goto, K., & Masaki, T. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81197-0 · Cited by 222
Urinary excretion of endothelin-1 in normal subjects and patients with renal disease
Ohta, K., Hirata, Y., Shichiri, M., et al. (1991) · Kidney International · doi:10.1038/ki.1991.38 · Cited by 152
Self-citationEffects of Angiotensin II on DNA, RNA and Protein Synthesis
Khairallah, P. A., Robertson, A. L., & Davila, D. (1972) · Springer eBooks · doi:10.1007/978-3-642-65343-8_28 · Cited by 80
Neyses, L., Nouskas, J., & Vetter, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81376-2 · Cited by 45
Cited by
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., & Itescu, S. (2001) · Nature Medicine · doi:10.1038/86498 · Cited by 2,540
Neural Control of Renal Function*
Kopp, U. C., & DiBona, G. F. (2020) · Reflex Control of the Circulation · doi:10.1201/9780367813338-17 · Cited by 1,126
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., & Yanagisawa, M. (1994) · Cell · doi:10.1016/0092-8674(94)90425-1 · Cited by 921
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Metadata
- Authors
- Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., Nogami, A., Murumo, F., & Hiroe, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 398-403
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2044261018
- Cited by
- 573
- References
- 22
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.